Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit
4.6 (790) · € 35.50 · Auf Lager
Neulasta® (pegfilgrastim) Onpro® kit
![Wearable injectors news and trends](https://www.springboard.pro/wp-content/uploads/2022/09/Illustration-SensAir-CMYK-2-300x169.png)
Wearable injectors news and trends
![Pegfilgrastim Biosimilar Market Size, Demand & Growth Report](https://www.factmr.com/images/reports/pegfilgrastim-biosimilar-market-forecast-2023-2033.jpg)
Pegfilgrastim Biosimilar Market Size, Demand & Growth Report
![Amgen 2018: Company-wide transformation - PharmaLive](https://www.pharmalive.com/wp-content/uploads/2018/10/Sensipar_90mg_Tab_frnt.jpg)
Amgen 2018: Company-wide transformation - PharmaLive
![Access & Resources Neulasta® (pegfilgrastim) Onpro®](https://www.neulastahcp.com/-/media/Themes/Amgen/neulastahcp-com/neulastahcp-com/images/access-and-resources/amgen-firststep-card.png?h=566&iar=0&w=679&hash=F5CDE9A23FA5D9C93154B008F0CD7C7D)
Access & Resources Neulasta® (pegfilgrastim) Onpro®
Neulasta® (pegfilgrastim) Onpro® kit
![Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma - MedNews](https://media.drugs.com/wp-content/uploads/2023/06/1c6824a5-8c2a-43f8-bd14-ee90d8f1ce5d.png)
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma - MedNews
![WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS - ONdrugDelivery](http://ondrugdelivery.com/wp-content/uploads/2020/09/111_Sep_2020_springboard_Figure_3.png)
WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS - ONdrugDelivery
![How Risky Was Amgen's Onpro Advertising?](https://cdn.sanity.io/images/0vv8moc6/biosimilars/d0d794fc99bd947ca36925570208f244c32c1cbf-970x356.png?fit=crop&auto=format)
How Risky Was Amgen's Onpro Advertising?
![Biosimilars 2021 Year in Review](https://jdsupra-html-images.s3-us-west-1.amazonaws.com/b273a9ab-1b3b-4eed-b479-5cbafa2f84e3-Biosimilars-Chart-1.png)
Biosimilars 2021 Year in Review
![Coherus' newly minted Neulasta biosim steps up pressure on Amgen](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1541434871/dosing-01-retina.jpg/dosing-01-retina.jpg?VersionId=kU7tl64JbFK7Jw0FZMM1IM6wfv3qYgDi)
Coherus' newly minted Neulasta biosim steps up pressure on Amgen
![Humira, Radio Compass Blog, Latest Pharmaceutical Articles](https://www.pharmacompass.com/image/news/banner/fda-reports-625-growth-in-new-drug-approvals-in-h1-2023-ema-health-canada-see-drop-96668.png)
Humira, Radio Compass Blog, Latest Pharmaceutical Articles